FDA Brief

Company record

Focalyx Technologies, LLC.

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Focalyx Technologies, LLC..

Recalls

ReportedClassFirmProduct and reason
Feb 11 Class II Focalyx Technologies, LLC.
Device
Focalyx Fusion
Software device that is an accessory for image-guided interventional and diagnostic procedures involving prostate has accessories that may not function properly with Windows 10, which may cause patient harm during biopsy or cause treatment/therapy delays, so firm is recommending stop use until device is verified/validated with Windows 11.
FDA notice Z-1243-2026